德尔尼多心脏的替代基础解决方案:组成,理由和临床证据
1Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Interdisciplinary cardiovascular and thoracic surgery
|January 13, 2026
概括
替代解决方案,如正常盐水和乳酸林格的是有效的德尔尼多心脏. 这些安全和经济高效的选择提供了与Plasma-Lyte A.A.相比较的心肌保护.
科学领域:
- 心脏病学 心脏病学
- 心血管外科心血管外科
- 麻醉学 麻醉学
背景情况:
- 德尔尼多心脏越来越多地用于成人心脏手术.
- 它的原始配方使用了Plasma-Lyte A作为基溶液.
研究的目的:
- 审查组成和证据,以替代基础解决方案.
- 评估这些替代品的安全性和有效性.
主要方法:
- 进行了全面的文献审查.
- 包括实验性,观察性和随机临床研究,比较改性德尔尼多心脏与各种晶体.
主要成果:
- 德尔尼多心脏与替代晶体质 (正常盐水,林格,伊索利特S,Ionosteril,全血) 显示了与Plasma-Lyte A.相比的心肌保护和结果.
- 有效的缓冲和补充对于替代解决方案至关重要.
结论:
- 替代基解决方案是安全,有效和经济高效的替代品,用于Plasma-Lyte A in del Nido心脏.
- 需要进一步的多中心研究来确认长期的安全性并支持全球采用.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
645
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
645
Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy
464
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
464
Heart Failure VI: Adjunct Therapies
252
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
252
Depolarizing Blockers: Pharmocokinetics
562
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
562
Cardiomyopathy V: Interprofessional Care
335
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335


